RLMD insider transactions
Relmada Therapeutics Inc. (RLMD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for RLMD
- Chief Executive Officer Traversa Sergio bought $113,300 worth of shares (27,500 units at $4.12), increasing direct ownership by 2% to 1,300,000 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Financial Officer Shenouda Maged bought $48,060 worth of shares (11,665 units at $4.12), increasing direct ownership by 1% to 800,000 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by CA and CO Ence Chuck4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Director Fedeli Fabiana4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Director Glasspool John4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by COO Kelly Paul Edward4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Director Casamento Charles J4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Operating Officer Kelly Paul Edward bought $198,000 worth of shares (90,000 units at $2.20), increasing direct ownership by 22% to 502,295 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Executive Officer Traversa Sergio bought $599,500 worth of shares (272,500 units at $2.20), increasing direct ownership by 27% to 1,272,500 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- CAO and COO Ence Chuck bought $299,200 worth of shares (136,000 units at $2.20), increasing direct ownership by 51% to 403,931 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Financial Officer Shenouda Maged bought $1,100,000 worth of shares (500,000 units at $2.20), increasing direct ownership by 173% to 788,335 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Executive Officer Traversa Sergio bought $178,095 worth of shares (265,976 units at $0.67), increasing direct ownership by 36% to 1,000,000 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by CA and CO Ence Chuck4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Shenouda Maged4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Traversa Sergio4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Director Casamento Charles J4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Director Glasspool John4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Director Fedeli Fabiana4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Kelly Paul Edward4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Operating Officer Kelly Paul Edward bought $86,060 worth of shares (200,000 units at $0.43), increasing direct ownership by 94% to 412,295 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Financial Officer Shenouda Maged bought $97,208 worth of shares (200,000 units at $0.49), increasing direct ownership by 226% to 288,335 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- CA and CO Ence Chuck bought $103,330 worth of shares (228,961 units at $0.45), increasing direct ownership by 588% to 267,931 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Executive Officer Traversa Sergio bought $174,713 worth of shares (350,000 units at $0.50), increasing direct ownership by 91% to 734,024 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Director Casamento Charles J gifted 13,000 shares, closing all direct ownership in the company (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Executive Officer Traversa Sergio bought $395,115 worth of shares (140,000 units at $2.82), increasing direct ownership by 57% to 384,024 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Director Casamento Charles J bought $33,280 worth of shares (13,000 units at $2.56) (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Chief Financial Officer Shenouda Maged bought $149,701 worth of shares (53,432 units at $2.80), increasing direct ownership by 153% to 88,335 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Director Kelly Paul Edward bought $64,750 worth of shares (25,000 units at $2.59), increasing direct ownership by 13% to 212,295 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Traversa Sergio4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Shenouda Maged4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Kelly Paul Edward4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Glasspool John4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Fedeli Fabiana4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Ence Chuck4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Casamento Charles J4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Traversa Sergio bought $386,738 worth of shares (100,000 units at $3.87), increasing direct ownership by 69% to 244,024 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Shenouda Maged bought $125,717 worth of shares (32,675 units at $3.85), increasing direct ownership by 1,467% to 34,903 units (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- Ence Chuck bought $150,920 worth of shares (38,970 units at $3.87) (SEC Form 4)4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Traversa Sergio4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Shenouda Maged4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Kelly Paul Edward4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Glasspool John4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Fedeli Fabiana4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Ence Chuck4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Casamento Charles J4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Traversa Sergio4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Shenouda Maged4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Schmidt Eric Thomas4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Kelly Paul Edward4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Glasspool John4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Fedeli Fabiana4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Ence Chuck4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by Casamento Charles J4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by O'Gorman Cedric4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 5 filed by Traversa Sergio (Amendment)5/A - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 5 filed by Traversa Sergio5 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 5 filed by Kelly Paul Edward5 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 5: Casamento Charles J closing all direct ownership in the company5 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 3 filed by new insider Fedeli Fabiana3 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)
- SEC Form 4 filed by O'Gorman Cedric4 - RELMADA THERAPEUTICS, INC. (0001553643) (Issuer)